Trial · NCT06960369
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
To evaluate the overall efficacy of repeated Transcranial Magnetic Stimulation(rTMS) combined with a Live Probiotic tablet (Combined Bifidobacterium, Lactobacil
- Status
- Recruiting
- Sponsor
- The First Affiliated Hospital of Soochow University
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 400 participants (planned)
- Start
- Dec 1, 2024
- Primary completion
- Jun 1, 2026
- Conditions
- Irritable Bowel Syndrome, Irritable Bowel Syndrome With Diarrhea (IBS-D), Repetitive Transcranial Magnetic Stimulation (rTMS), Probiotic, Chronic Diarrhea, Intestinal Flora
Summary
To evaluate the overall efficacy of repeated Transcranial Magnetic Stimulation(rTMS) combined with a Live Probiotic tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Methods: Clinical efficacy evaluation of TMS combined with Live Probiotic tablet for chronic diarrhea in IBS patients.
Interventions
- rTMS combined with Live Probiotic tablet Combination product
- rTMS combined placebo Device
- shamrTMS combined with Live Probiotic tablet Drug
- shamrTMS combined placebo group Other
Locations
1 country: China.
| Facility | City | Country |
|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou, Jiangsu | China |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.